Bridgewater Advisors Inc. Astrazeneca PLC Transaction History
Bridgewater Advisors Inc.
- $959 Million
- Q3 2024
A detailed history of Bridgewater Advisors Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Bridgewater Advisors Inc. holds 10,333 shares of AZN stock, worth $752,655. This represents 0.08% of its overall portfolio holdings.
Number of Shares
10,333
Previous 10,314
0.18%
Holding current value
$752,655
Previous $804,000
0.12%
% of portfolio
0.08%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,341Shares Held
492MCall Options Held
4.99MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.73 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.1 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.96 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.67 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.28 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $226B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...